Zogenix, Inc.

ZGNXCIK 0001375151 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Mar 7, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0016

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Zogenix, Inc.

Name	Roles	Filings
Mast Erle T	Director	3
Bock Louis C	Director	1
Breitmeyer James B	Director	1
Farr Stephen J	OfficerDirector	1
Farfel Gail M	Officer	1

Showing 1-5 of 15

Per pagePage 1 of 3Next

All filings

17 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 9, 2022	Loewy Caroline M Director	Holdings only	-	-	-
Mar 9, 2022	Galer Bradley S. EVP & Chief Medical Officer	UTender	25,022	-	-
Mar 9, 2022	Mast Erle T Director	UTender	3,027	-	-
Mar 9, 2022	Farfel Gail M See Remarks	UTender	16,606	-	-
Mar 9, 2022	Tannenbaum Renee P Director	UTender	32,567	-	-

Showing 6-10 of 17

Per pagePrevPage 2 of 4Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value